Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea
- PMID: 25913530
- DOI: 10.1111/apt.13227
Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea
Abstract
Background: Irritable bowel syndrome is a widespread disorder with a marked socioeconomic burden. Previous studies support the proposal that a subset of patients with features compatible with diarrhoea-predominant IBS (IBS-D) have bile acid malabsorption (BAM).
Aim: To perform a systematic review and meta-analysis to assess the prevalence of BAM in patients meeting the accepted criteria for IBS-D.
Methods: MEDLINE and EMBASE were searched up to March 2015. Studies recruiting adults with IBS-D, defined by the Manning, Kruis, Rome I, II or III criteria and which used 23-seleno-25-homotaurocholic acid (SeHCAT) testing for the assessment of BAM were included. BAM was defined as 7 day SeHCAT retention of <10%. We calculated the rate of BAM and 95% confidence intervals (CI) using a random effects model. The methodological quality of included studies was evaluated using the Quality Assessment for Diagnostic Accuracy Studies (QUADAS-2).
Results: The search strategy identified six relevant studies comprising 908 individuals. The rate of BAM ranged from 16.9% to 35.3%. The pooled rate was 28.1% (95% CI: 22.6-34%). There was significant heterogeneity in effect sizes (Q-test χ(2) = 17.9, P < 0.004; I(2) = 72.1%). The type of diagnostic criteria used or study country did not significantly modify the effect.
Conclusions: These data provide evidence that in excess of one quarter of patients meeting accepted criteria for IBS-D have bile acid malabsorption. This distinction has implications for the interpretation of previous studies, as well as contemporaneous clinical practice and future guideline development.
© 2015 John Wiley & Sons Ltd.
Comment in
-
Letter: therapeutic trial is more informative than SeHCAT to diagnose bile acid malabsorption.Aliment Pharmacol Ther. 2015 Sep;42(6):780. doi: 10.1111/apt.13320. Aliment Pharmacol Ther. 2015. PMID: 26278567 No abstract available.
-
Letter: therapeutic trial is more informative than SeHCAT to diagnose bile acid malabsorption--authors' reply.Aliment Pharmacol Ther. 2015 Sep;42(6):781. doi: 10.1111/apt.13337. Aliment Pharmacol Ther. 2015. PMID: 26278568 No abstract available.
Similar articles
-
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.Aliment Pharmacol Ther. 2009 Oct;30(7):707-17. doi: 10.1111/j.1365-2036.2009.04081.x. Epub 2009 Jun 30. Aliment Pharmacol Ther. 2009. PMID: 19570102 Review.
-
SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2013 Dec;17(61):1-236. doi: 10.3310/hta17610. Health Technol Assess. 2013. PMID: 24351663 Free PMC article. Review.
-
Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.J Clin Gastroenterol. 2023 May-Jun 01;57(5):451-458. doi: 10.1097/MCG.0000000000001841. Epub 2023 Mar 6. J Clin Gastroenterol. 2023. PMID: 36867517
-
Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.Scand J Gastroenterol. 2011 Jul;46(7-8):818-22. doi: 10.3109/00365521.2011.574728. Epub 2011 Apr 15. Scand J Gastroenterol. 2011. PMID: 21492055
-
Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.Neurogastroenterol Motil. 2012 Nov;24(11):983-e538. doi: 10.1111/j.1365-2982.2012.01953.x. Epub 2012 Jul 5. Neurogastroenterol Motil. 2012. PMID: 22765392
Cited by
-
Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice.Frontline Gastroenterol. 2019 Sep 11;11(5):358-363. doi: 10.1136/flgastro-2019-101301. eCollection 2020. Frontline Gastroenterol. 2019. PMID: 32879719 Free PMC article.
-
Novel associations of bile acid diarrhoea with fatty liver disease and gallstones: a cohort retrospective analysis.BMJ Open Gastroenterol. 2017 Oct 26;4(1):e000178. doi: 10.1136/bmjgast-2017-000178. eCollection 2017. BMJ Open Gastroenterol. 2017. PMID: 29119003 Free PMC article.
-
Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.World J Gastroenterol. 2020 Dec 7;26(45):7153-7172. doi: 10.3748/wjg.v26.i45.7153. World J Gastroenterol. 2020. PMID: 33362374 Free PMC article.
-
Measurement of serum 7α-hydroxy-4-cholesten-3-one as a marker of bile acid malabsorption in dogs with chronic diarrhoea: a pilot study.Vet Rec Open. 2016 Apr 6;3(1):e000163. doi: 10.1136/vetreco-2015-000163. eCollection 2016. Vet Rec Open. 2016. PMID: 27110372 Free PMC article.
-
Irritable bowel syndrome.Nat Rev Dis Primers. 2016 Mar 24;2:16014. doi: 10.1038/nrdp.2016.14. Nat Rev Dis Primers. 2016. PMID: 27159638 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous